quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:12:34·672d
NEWSRelease
Centogene N.V. logo

Centogene And C-Path Sign MOU For Collaboration In Lysosomal Disease Research And Drug Development

CNTG· Centogene N.V.
Health Care
Original source

Companies

  • CNTG
    Centogene N.V.
    Health Care

Recent analyst ratings

  • Aug 5UpdateCredit Suisse$14.00

Related

  • PR407d
    CENTOGENE Closes Strategic Transaction with Private Equity Group Charme Capital Partners
  • PR505d
    CENTOGENE Announces Voting Results of Extraordinary General Meeting
  • PR526d
    CENTOGENE Signs Strategic Transaction With Private Equity Group Charme Capital Partners
  • PR575d
    CENTOGENE Data on Novel Genetic Risk Factor for Parkinson's Disease in The Lancet Neurology
  • SEC612d
    SEC Form 6-K filed by Centogene N.V.
  • SEC624d
    SEC Form 6-K filed by Centogene N.V.
  • PR624d
    CENTOGENE Receives Delisting Notice From Nasdaq
  • SEC630d
    SEC Form 6-K filed by Centogene N.V.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022